SK16522000A3 - Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie - Google Patents

Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie Download PDF

Info

Publication number
SK16522000A3
SK16522000A3 SK1652-2000A SK16522000A SK16522000A3 SK 16522000 A3 SK16522000 A3 SK 16522000A3 SK 16522000 A SK16522000 A SK 16522000A SK 16522000 A3 SK16522000 A3 SK 16522000A3
Authority
SK
Slovakia
Prior art keywords
chloronaphth
benzoyl
piperazine
compound
pyridyl
Prior art date
Application number
SK1652-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Marianne Ashford
Roger James
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK16522000A3 publication Critical patent/SK16522000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SK1652-2000A 1998-05-02 1999-04-27 Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie SK16522000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (1)

Publication Number Publication Date
SK16522000A3 true SK16522000A3 (sk) 2001-05-10

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1652-2000A SK16522000A3 (sk) 1998-05-02 1999-04-27 Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie

Country Status (16)

Country Link
EP (1) EP1084118A1 (no)
JP (1) JP2002513789A (no)
KR (1) KR20010043216A (no)
CN (1) CN1308629A (no)
AU (1) AU3719699A (no)
BR (1) BR9910176A (no)
CA (1) CA2331041A1 (no)
EE (1) EE200000638A (no)
GB (1) GB9809350D0 (no)
HU (1) HUP0102394A3 (no)
IL (1) IL139405A0 (no)
NO (1) NO20005498L (no)
PL (1) PL343705A1 (no)
SK (1) SK16522000A3 (no)
WO (1) WO1999057112A1 (no)
ZA (1) ZA200006036B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9815377A (pt) 1997-09-30 2001-01-16 Daiichi Pharmaceutical Co Ltda Derivados de sulfonil
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
CA2287292A1 (en) * 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
BR9815377A (pt) * 1997-09-30 2001-01-16 Daiichi Pharmaceutical Co Ltda Derivados de sulfonil

Also Published As

Publication number Publication date
NO20005498D0 (no) 2000-11-01
NO20005498L (no) 2000-11-01
EP1084118A1 (en) 2001-03-21
CN1308629A (zh) 2001-08-15
PL343705A1 (en) 2001-08-27
AU3719699A (en) 1999-11-23
IL139405A0 (en) 2001-11-25
EE200000638A (et) 2002-04-15
HUP0102394A2 (hu) 2001-12-28
ZA200006036B (en) 2002-01-25
HUP0102394A3 (en) 2003-01-28
KR20010043216A (ko) 2001-05-25
JP2002513789A (ja) 2002-05-14
GB9809350D0 (en) 1998-07-01
WO1999057112A1 (en) 1999-11-11
CA2331041A1 (en) 1999-11-11
BR9910176A (pt) 2001-01-09

Similar Documents

Publication Publication Date Title
RU2067975C1 (ru) 1,2-дигидро-2-оксопиридины, их физиологически приемлемые соли и фармацевтическая композиция
US5731324A (en) Glycoprotein IIb/IIIa antagonists
WO1998006433A1 (fr) MEDICAMENTS COMPRENANT UN INHIBITEUR DE LA Rho KINASE
BG102948A (bg) Пиразинони като инхибитори на тромбин
EP2138482A1 (en) Bicyclic heterocyclic compound
TW200402416A (en) Novel piperidine derivatives
EP0562599A1 (en) Condensed thiadiazole derivative, method of its production, and use thereof
JP2002525370A (ja) トロンビン阻害剤
EP1153014B1 (de) Beta-alaninderivate
US6326386B1 (en) Benzamide derivatives as thrombin inhibitors
JP4248245B2 (ja) ６−フェニルベンゾナフチリジン
JPH093066A (ja) クロモン誘導体
DE19713000A1 (de) Adhäsionsrezeptor-Antagonisten
JPWO2003011812A1 (ja) ヒト−β−トリプターゼ阻害活性を有する新規アミン誘導体およびそれを含有する医薬
SK16522000A3 (sk) Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie
EP3068763B1 (en) Hydrobromide salt of n-(4-chloro-2-hydroxy-3-((3s)-3-piperidinylsulfonyl)phenyl)-n'-(3-fluoro-2-methylphenyl)urea
JP2007532626A (ja) Ｈｉｖ治療用硫黄連結イミダゾール化合物
TWI257389B (en) Pharmaceutical compound
US7674792B2 (en) 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
WO2001017990A1 (en) Heterocyclic derivatives as inhibitors of factor xa
WO2001092234A1 (en) Pyrazinone thrombin inhibitors
US20080194635A1 (en) Crystalline Forms of Cis-5-Fluoro-N-[4-(2-Hydroxy-4-Methylbenzamido) Cyclohexyl]-2-(Tetrahydrothiopyran-4-Yloxy) Nicotinamide
CZ20004037A3 (cs) Forma l-(6-chlornaft-2-ylsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazinu se zmenšenu velikostí částic a farmaceutická kompozice tuto formu obsahující
JP3457281B2 (ja) トロンビン阻害剤としてのベンズアミド誘導体
MXPA00010676A (en) Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl]piperazine